Development of Pleiotropic TrkB and 5-HT 4 Receptor Ligands as Neuroprotective Agents.

Autor: Antonijevic, Mirjana, Charou, Despoina, Davis, Audrey, Curel, Thomas, Valcarcel, Maria, Ramos, Isbaal, Villacé, Patricia, Claeysen, Sylvie, Dallemagne, Patrick, Gravanis, Achille, Charalampopoulos, Ioannis, Rochais, Christophe
Předmět:
Zdroj: Molecules; Jan2024, Vol. 29 Issue 2, p515, 20p
Abstrakt: One common event that is the most detrimental in neurodegenerative disorders, even though they have a complex pathogenesis, is the increased rate of neuronal death. Endogenous neurotrophins consist of the major neuroprotective factors, while brain-derived neurotrophic factor (BDNF) and its high-affinity tyrosine kinase receptor TrkB are described in a number of studies for their important neuronal effects. Normal function of this receptor is crucial for neuronal survival, differentiation, and synaptic function. However, studies have shown that besides direct activation, the TrkB receptor can be transactivated via GPCRs. It has been proven that activation of the 5-HT4 receptor and transactivation of the TrkB receptor have a positive influence on neuronal differentiation (total dendritic length, number of primary dendrites, and branching index). Because of that and based on the main structural characteristics of LM22A-4, a known activator of the TrkB receptor, and RS67333, a partial 5-HT4 receptor agonist, we have designed and synthesized a small data set of novel compounds with potential dual activities in order to not only prevent neuronal death, but also to induce neuronal differentiation in neurodegenerative disorders. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje